Current Enzyme Inhibition
Title:Meet Our Co-Editor
Volume: 11 Issue: 2
Author(s): Dimitra Hadjipavlou-Litina
Affiliation:
Export Options
About this article
Cite this article as:
Hadjipavlou-Litina Dimitra, Meet Our Co-Editor, Current Enzyme Inhibition 2015; 11 (2) . https://dx.doi.org/10.2174/157340801102151019112938
DOI https://dx.doi.org/10.2174/157340801102151019112938 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hepatitis C Virus Clearance: The Enigma of Failure Despite an Impeccable Survival Strategy
Current Pharmaceutical Biotechnology Integration of Physicochemical and Pharmacokinetic Parameters in Lead Optimization: A Physiological Pharmacokinetic Model Based Approach
Current Drug Discovery Technologies Linear Naphtho-γ-Pyrones: A Naturally Occurring Scaffold of Biological Importance
Mini-Reviews in Medicinal Chemistry Evolution of Specific Cognitive Subprofiles of Mild Cognitive Impairment in a Three-Year Longitudinal Study
Current Aging Science The Hypothalamus and Obesity
Recent Patents on CNS Drug Discovery (Discontinued) Members of CRF Family and their Receptors: From Past to Future
Current Medicinal Chemistry Immunomodulatory Strategies for Huntington's Disease Treatment
CNS & Neurological Disorders - Drug Targets Cell-based Assays for Assessing Toxicity: A Basic Guide
Medicinal Chemistry Conspectus of Phytoconstituents and Pharmacological Activities of <i>Barleria lupulina</i> Lindl.: A Review
Current Traditional Medicine Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
Current Alzheimer Research Gender Differences in the Treatment of Ischemic Heart Disease
Current Pharmaceutical Design The Influence of Ca<sup>2+</sup> and Zn<sup>2+</sup> on the Amyloid Fibril Formation by β-Casein
Protein & Peptide Letters Oxidative Stress Signaling in Alzheimers Disease
Current Alzheimer Research Meet Our Editorial Board Member
Current Aging Science TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse
Current Medicinal Chemistry - Central Nervous System Agents Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Central Nervous System Agents in Medicinal Chemistry Transgenic Mice as a Model for Alzheimers Disease
Current Alzheimer Research Interleukin-1β Increases Release of Endothelin-1 and Tumor Necrosis Factor as Well as Reactive Oxygen Species by Peripheral Leukocytes During Experimental Subarachnoid Hemorrhage
Current Neurovascular Research